195 related articles for article (PubMed ID: 30976784)
1. Characterizing the selectivity of ER α-glucosidase inhibitors.
O'Keefe S; Roebuck QP; Nakagome I; Hirono S; Kato A; Nash R; High S
Glycobiology; 2019 Jul; 29(7):530-542. PubMed ID: 30976784
[TBL] [Abstract][Full Text] [Related]
2. Casuarine stereoisomers from achiral substrates: chemoenzymatic synthesis and inhibitory properties.
Concia AL; Gómez L; Parella T; Joglar J; Clapés P
J Org Chem; 2014 Jun; 79(11):5386-9. PubMed ID: 24810734
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory properties of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) derivatives acting on glycogen metabolising enzymes.
Díaz-Lobo M; Concia AL; Gómez L; Clapés P; Fita I; Guinovart JJ; Ferrer JC
Org Biomol Chem; 2016 Sep; 14(38):9105-9113. PubMed ID: 27714243
[TBL] [Abstract][Full Text] [Related]
4. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
[TBL] [Abstract][Full Text] [Related]
5. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
[TBL] [Abstract][Full Text] [Related]
6. Strategy for Designing Selective Lysosomal Acid α-Glucosidase Inhibitors: Binding Orientation and Influence on Selectivity.
Kato A; Nakagome I; Hata M; Nash RJ; Fleet GWJ; Natori Y; Yoshimura Y; Adachi I; Hirono S
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575625
[TBL] [Abstract][Full Text] [Related]
7. ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity.
Kiappes JL; Hill ML; Alonzi DS; Miller JL; Iwaki R; Sayce AC; Caputo AT; Kato A; Zitzmann N
ACS Chem Biol; 2018 Jan; 13(1):60-65. PubMed ID: 29161006
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.
Karade SS; Franco EJ; Rojas AC; Hanrahan KC; Kolesnikov A; Yu W; MacKerell AD; Hill DC; Weber DJ; Brown AN; Treston AM; Mariuzza RA
J Med Chem; 2023 Feb; 66(4):2744-2760. PubMed ID: 36762932
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of Labystegines, Hybrid Iminosugars from LAB and Calystegine, as Inhibitors of Intestinal α-Glucosidases: Binding Conformation and Interaction for ntSI.
Kato A; Zhang ZL; Wang HY; Jia YM; Yu CY; Kinami K; Hirokami Y; Tsuji Y; Adachi I; Nash RJ; Fleet GW; Koseki J; Nakagome I; Hirono S
J Org Chem; 2015 May; 80(9):4501-15. PubMed ID: 25843107
[TBL] [Abstract][Full Text] [Related]
10. Chemo-enzymatic synthesis and glycosidase inhibitory properties of DAB and LAB derivatives.
Concia AL; Gómez L; Bujons J; Parella T; Vilaplana C; Cardona PJ; Joglar J; Clapés P
Org Biomol Chem; 2013 Mar; 11(12):2005-21. PubMed ID: 23381224
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of glycoprotein-processing enzymes. Differential inhibition of glucosidases I and II in cell culture.
Kaushal GP; Pan YT; Tropea JE; Mitchell M; Liu P; Elbein AD
J Biol Chem; 1988 Nov; 263(33):17278-83. PubMed ID: 3053707
[TBL] [Abstract][Full Text] [Related]
12. Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
Caputo AT; Alonzi DS; Marti L; Reca IB; Kiappes JL; Struwe WB; Cross A; Basu S; Lowe ED; Darlot B; Santino A; Roversi P; Zitzmann N
Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4630-8. PubMed ID: 27462106
[TBL] [Abstract][Full Text] [Related]
13. Cell wall 1,6-beta-glucan synthesis in Saccharomyces cerevisiae depends on ER glucosidases I and II, and the molecular chaperone BiP/Kar2p.
Simons JF; Ebersold M; Helenius A
EMBO J; 1998 Jan; 17(2):396-405. PubMed ID: 9430631
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
Miller JL; Tyrrell BE; Zitzmann N
Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
Chang J; Block TM; Guo JT
Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of 3'-benzylated analogs of 3'-epi-neoponkoranol as potent α-glucosidase inhibitors.
Liu D; He W; Wang Z; Liu L; Wang C; Zhang C; Wang C; Wang Y; Tanabe G; Muraoka O; Wu X; Wu L; Xie W
Eur J Med Chem; 2016 Mar; 110():224-36. PubMed ID: 26840363
[TBL] [Abstract][Full Text] [Related]
17. Oligosaccharide trimming Man9-mannosidase is a resident ER protein and exhibits a more restricted and local distribution than glucosidase II.
Roth J; Brada D; Lackie PM; Schweden J; Bause E
Eur J Cell Biol; 1990 Oct; 53(1):131-41. PubMed ID: 2076700
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of
Wang H; Tang S; Zhang G; Pan Y; Jiao W; Shao H
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080282
[TBL] [Abstract][Full Text] [Related]
19. Importance of glycosidases in mammalian glycoprotein biosynthesis.
Herscovics A
Biochim Biophys Acta; 1999 Dec; 1473(1):96-107. PubMed ID: 10580131
[TBL] [Abstract][Full Text] [Related]
20. Polyhydroxylated Quinolizidine Iminosugars as Nanomolar Selective Inhibitors of α-Glucosidases.
Vieira Da Cruz A; Kanazawa A; Poisson JF; Behr JB; Py S
J Org Chem; 2017 Sep; 82(18):9866-9872. PubMed ID: 28752763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
